title: [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). I. Susceptibility distribution].
abstract: The bacterial strains isolated from 565 patients diagnosed as having urinary tract infections (UTIs) in 14 institutions in Japan were collected between August 2003 and July 2004. The susceptibilities of them to many kinds of antimicrobial agents were investigated. Of them, 701 strains were estimated as prophlogistic bacteria and used for the investigation. The strains consisted of 258 Gram-positive bacterial strains (36.8%) and 443 Gram-negative bacterial strains (63.2%). Against Staphylococcus aureus, vancomycin (VCM) showed the strongest activity and prevented the growth of all strains with 2 microg/mL. Against Streptococcus agalactiae, ampicillin (ABPC), cefozopran (CZOP), imipenem (IPM), and clarithromycin (CAM) showed a strong activity and the MIC90 was 0.125 microg/mL or less. Against Enterococcus faecalis, VCM, ABPC, and IPM showed a strong antibacterial activity. The antibacterial activity of cephems to Escherichia coli was generally good, and especially CZOP and cefpirome (CPR) showed the strongest activity (MIC90: < or = 0.125 microg/mL). Quinolone resistant E. coli [MIC of ciprofloxacin (CPFX): > or =4 microg/mL] was detected at frequency of 15.7%, which was higher than that in the last year. Against Klebsiella pneumoniae, meropenem (MEPM) showed the strongest activity and next, the antibacterial activity of CRMN and CZOP was good. The antibacterial activity of the other cephems, however, significantly decreased, compared with that evaluated in last year. Against Serratia marcescens, MEPM had the strongest antibacterial activity. Against Proteus mirabilis, MEPM and CRMN showed the strongest activity and prevented the growth of all strains with 0.125 microg/mL or less. Nest, cefmenoxime (CMX), ceftazidime (CAZ), cefixime (CFIX), cefpodoxime (CPDX), CPR, CZOP, and cefditoren (CDTR) showed a strong activity. The antibacterial activity of the drugs to Pseudomonas aeruginosa was generally low, and MIC90 of all the drugs was ranged from 32 to < or = 256 microg/mL except IPM and amikacin (AMK) having 16 microg/mL. The antibacterial activity of CZOP was relatively good (MIC50: 2 microg/mL).
authors.affiliation: Department of Urology, Sapporo Medical University School of Medicine.
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kumamoto
authors.forename: Taiji
authors.initials: T
authors.lastname: Tsukamoto
authors.forename: Masanori
authors.initials: M
authors.lastname: Matsukawa
authors.forename: Yasuharu
authors.initials: Y
authors.lastname: Kunishima
authors.forename: Kiyoaki
authors.initials: K
authors.lastname: Watanabe
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Uchida
authors.forename: Seiji
authors.initials: S
authors.lastname: Matsuda
authors.forename: Takaoki
authors.initials: T
authors.lastname: Hirose
authors.forename: Shinichi
authors.initials: S
authors.lastname: Sato
authors.forename: Shiro
authors.initials: S
authors.lastname: Shigeta
authors.forename: Makoto
authors.initials: M
authors.lastname: Fujime
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Fujita
authors.forename: Osamu
authors.initials: O
authors.lastname: Yamaguti
authors.forename: Kei
authors.initials: K
authors.lastname: Ishibashi
authors.forename: Jun
authors.initials: J
authors.lastname: Igari
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Suzutani
authors.forename: Toyoko
authors.initials: T
authors.lastname: Oguri
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yoshida
authors.forename: Yuuji
authors.initials: Y
authors.lastname: Imafuku
authors.forename: Keizo
authors.initials: K
authors.lastname: Yamaguchi
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Furuya
authors.forename: Masaru
authors.initials: M
authors.lastname: Murai
authors.forename: Takashi
authors.initials: T
authors.lastname: Deguchi
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ishihara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ooe
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Koichi
authors.initials: K
authors.lastname: Takahashi
authors.forename: Mineko
authors.initials: M
authors.lastname: Nishikawa
authors.forename: Seiji
authors.initials: S
authors.lastname: Naito
authors.forename: Toshihisa
authors.initials: T
authors.lastname: Egashira
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Konishi
authors.forename: Toshitsugu
authors.initials: T
authors.lastname: Oka
authors.forename: Masaya
authors.initials: M
authors.lastname: Kitamura
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kohno
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Fukuhara
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Hirakata
authors.forename: Akira
authors.initials: A
authors.lastname: Kondo
authors.forename: Junichi
authors.initials: J
authors.lastname: Matsuda
authors.forename: Michiko
authors.initials: M
authors.lastname: Nakano
authors.forename: Sadao
authors.initials: S
authors.lastname: Kamidono
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Soichi
authors.initials: S
authors.lastname: Arakawa
authors.forename: Hiromi
authors.initials: H
authors.lastname: Kumon
authors.forename: Koichi
authors.initials: K
authors.lastname: Monden
mesh_terms: D004352:Drug Resistance, Microbial; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006801:Humans; D014552:Urinary Tract Infections / Q000382:microbiology*